Search Results
Department of Radiology, Jichi Medical University, School of Medicine, Shimotsuke, Tochigi, Japan
Search for other papers by Tomohiro Kikuchi in
Google Scholar
PubMed
Search for other papers by Shouhei Hanaoka in
Google Scholar
PubMed
Search for other papers by Takahiro Nakao in
Google Scholar
PubMed
Center for Frontier Medical Engineering, Chiba University, Yayoicho, Inage–ku, Chiba, Japan
Search for other papers by Yukihiro Nomura in
Google Scholar
PubMed
Search for other papers by Takeharu Yoshikawa in
Google Scholar
PubMed
Search for other papers by Ashraful Alam in
Google Scholar
PubMed
Search for other papers by Harushi Mori in
Google Scholar
PubMed
Search for other papers by Naoto Hayashi in
Google Scholar
PubMed
. The PET images were acquired with the following parameters: FOV, 700 mm; matrix size, 128 × 128; voxel size, 5.47 × 5.47 × 3.25 mm. Hypothyroidism and hyperthyroidism, defined as elevated and decreased thyroid-stimulating hormone (TSH) levels
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Search for other papers by Gilles Russ in
Google Scholar
PubMed
Search for other papers by Fernando Schmitt in
Google Scholar
PubMed
Search for other papers by Paula Soares in
Google Scholar
PubMed
Search for other papers by Tamas Solymosi in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
; FNA, fine-needle aspiration; FT3, free tri-iodothyronine; FT4, free thyroxine; Tg, thyroglobulin; TPO, thyroid peroxidase; TRAB, TSH receptor antibody; TSH, thyroid-stimulating hormone; US, ultrasound. Figure 2 Diagnostic workup and the
Search for other papers by Aglaia Kyrilli in
Google Scholar
PubMed
Search for other papers by Nunzia Tacelli in
Google Scholar
PubMed
Search for other papers by Lucia Russo in
Google Scholar
PubMed
Search for other papers by Laetitia Lebrun in
Google Scholar
PubMed
Search for other papers by Isabelle Salmon in
Google Scholar
PubMed
Search for other papers by Gilles Russ in
Google Scholar
PubMed
Search for other papers by Rodrigo Moreno-Reyes in
Google Scholar
PubMed
Search for other papers by Bernard Corvilain in
Google Scholar
PubMed
. Cancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid-stimulating hormone receptor gene mutations . Diagnostic Cytopathology 2018 46 369 – 377 . ( https://doi.org/10.1002/dc.23915 )
Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Search for other papers by Pi-Ling Chiang in
Google Scholar
PubMed
Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Sheng-Dean Luo in
Google Scholar
PubMed
Department of Nuclear Medicine, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Yen-Hsiang Chang in
Google Scholar
PubMed
Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Chen-Kai Chou in
Google Scholar
PubMed
Departments of Surgery, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Shun-Yu Chi in
Google Scholar
PubMed
Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Search for other papers by Yi-Fan Chen in
Google Scholar
PubMed
Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Department of Radiology, Jen-Ai Hospital, Dali Branch, Taichung, Taiwan
School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung City, Taiwan
Search for other papers by Wei-Che Lin in
Google Scholar
PubMed
significant improvements compared to baseline. There were no significant changes to thyroid function, including triiodothyronine (T3), free thyroxine (T4), and thyroid-stimulating hormone (TSH) serum levels from baseline to 6 months post RFA, the data of which
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain
Search for other papers by J L Reverter in
Google Scholar
PubMed
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain
Search for other papers by L Ferrer-Estopiñan in
Google Scholar
PubMed
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain
Search for other papers by F Vázquez in
Google Scholar
PubMed
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain
Search for other papers by S Ballesta in
Google Scholar
PubMed
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain
Search for other papers by S Batule in
Google Scholar
PubMed
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain
Search for other papers by A Perez-Montes de Oca in
Google Scholar
PubMed
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain
Search for other papers by C Puig-Jové in
Google Scholar
PubMed
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain
Search for other papers by M Puig-Domingo in
Google Scholar
PubMed
thyroid stimulating hormone (TSH) levels were observed between groups (2.7 ± 1.2 mU/mL vs 2.8 ± 0.9 mU/mL, respectively; P = 0.6). Cytological diagnoses were as follows: 93% of benign nodules were Bethesda category II and 7% were category III, whereas 9
Search for other papers by Rui Guo in
Google Scholar
PubMed
Search for other papers by Bowen Zheng in
Google Scholar
PubMed
Search for other papers by Tao Wu in
Google Scholar
PubMed
Search for other papers by Yufan Lian in
Google Scholar
PubMed
Search for other papers by Tinghui Yin in
Google Scholar
PubMed
Search for other papers by Yuting He in
Google Scholar
PubMed
Search for other papers by Jingya Qin in
Google Scholar
PubMed
Search for other papers by Zhicheng Yao in
Google Scholar
PubMed
Search for other papers by Wen Xu in
Google Scholar
PubMed
Search for other papers by Jie Ren in
Google Scholar
PubMed
; FT3, free triiodothyronine; FT4, free thyroxine; TSH: thyroid stimulating hormone. a value in parentheses is the range. Treatment efficacy in VRR The IAR of all target nodules was 100% confirmed by CEUS at 1 month. When we analyzed the
Nursing Department, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China
Search for other papers by Ziyu Wan in
Google Scholar
PubMed
Search for other papers by Ying Li in
Google Scholar
PubMed
Search for other papers by Xiaoqian Dong in
Google Scholar
PubMed
Search for other papers by Yue Kang in
Google Scholar
PubMed
Search for other papers by Juan Luo in
Google Scholar
PubMed
Search for other papers by Jiangang Wang in
Google Scholar
PubMed
Search for other papers by Pingting Yang in
Google Scholar
PubMed
Search for other papers by Yaqin Wang in
Google Scholar
PubMed
Search for other papers by Yinglong Duan in
Google Scholar
PubMed
Search for other papers by Jianfei Xie in
Google Scholar
PubMed
Search for other papers by Andy S K Cheng in
Google Scholar
PubMed
Public Health 2016 13 442 . ( https://doi.org/10.3390/ijerph13040442 ) 40 Babić Leko M Gunjača I Pleić N & Zemunik T . Environmental factors affecting thyroid-stimulating hormone and thyroid hormone levels . International Journal of
Search for other papers by Eduardo Crespo Vallejo in
Google Scholar
PubMed
Search for other papers by Antonio Hermosin in
Google Scholar
PubMed
Search for other papers by Manuel Gargallo in
Google Scholar
PubMed
Search for other papers by Álvaro Villalba in
Google Scholar
PubMed
Search for other papers by Eduardo Daguer in
Google Scholar
PubMed
Search for other papers by José Flores in
Google Scholar
PubMed
Search for other papers by Javier Periañez in
Google Scholar
PubMed
Search for other papers by Joaquim Amorín in
Google Scholar
PubMed
Search for other papers by Ernesto Santos in
Google Scholar
PubMed
). Regarding basal hormonal analytics, thyroid-stimulating hormone (TSH) and free thyroxine (FT4) levels were exclusively obtained. Ablation procedure All interventions were performed by an interventional radiology team, consisting of four physicians
University of Sheffield, Sheffield, UK
Search for other papers by Muhammad Fahad Arshad in
Google Scholar
PubMed
Search for other papers by Amardass Dhami in
Google Scholar
PubMed
Search for other papers by Gillian Quarrell in
Google Scholar
PubMed
University of Sheffield, Sheffield, UK
Search for other papers by Saba Prakash Balasubramanian in
Google Scholar
PubMed
Introduction Hypoparathyroidism is defined as low calcium levels in presence of inappropriately normal or low parathyroid hormone (PTH) levels ( 1 ). It is commonly treated with calcium and activated vitamin D supplements, which makes it the